Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of <i>Ginkgo biloba</i> extract EGb 761<sup>®</sup> in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol.

Frontiers in human neuroscience·2026
Same author

Appropriate use recommendations of the Spanish Society of Neurology's Behavioural Neurology and Dementia Study Group on anti-amyloid antibodies in the treatment of Alzheimer disease.

Neurologia·2026
Same author

Comprehensive neuropsychological assessment and FDG-PET imaging in patients with RFC1-related disorder.

Parkinsonism & related disorders·2026
Same author

Long-term effect of transcranial magnetic stimulation and transcranial electrical stimulation in primary progressive aphasia: study protocol for a randomised, double-blind clinical trial (RECONNECT-PLUS).

BMJ open·2026
Same author

Cognitive characterization of the behavioral variant of frontotemporal dementia using the Neuronorma battery.

Journal of Alzheimer's disease : JAD·2026
Same author

Diagnostic accuracy of the Multicultural Cognitive Examination (MCE) for detection of MCI and dementia in a diverse international cohort.

The Clinical neuropsychologist·2026

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Cristina Delgado-Alonso1, María Valles-Salgado1, Esther Valiente-Gordillo1

  • 1Hospital Clinico San Carlos, Madrid, Madrid, Spain.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括

通过将p-tau181等血液生物标志物与认知测试相结合,可以提高早期阿尔茨海默病 (AD) 的检测. 这种方法提高了早期AD识别的诊断准确性.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 生物标志物研究 生物标志物研究
  • 诊断发展 诊断发展

背景情况:

  • 早期发现阿尔茨海默病 (AD) 对于有效的治疗干预至关重要.
  • 像p-tau181和p-tau217这样的等离子体生物标志物显示出确定早期粉样蛋白病理学的前景.
  • 了解生物标志物的临床影响对于重新定义AD查中的认知评估至关重要.

研究的目的:

  • 确定生物标志物和认知测试的最佳组合,以早期检测AD.
  • 为了评估血液生物标志物和认知评估的诊断性能,在患有早期记忆丧失症状的患者.

主要方法:

  • 包括124名患有记忆丧失但没有功能障碍的患者.
  • 神经心理学评估和CSF生物标志物被用于评估和分类到AD或非AD组.
  • 测量了血清p-tau181和p-tau217,以及一系列综合性认知测试.

主要成果:

  • 血p-tau181和p-tau217显示出高的诊断准确性 (AUC为0.935和0.886).
  • 将p-tau181与ACE-III (记忆) 或ROCF (记忆) 结合使用时,AUC分别为0.949和0.964.
  • 表现最好的神经心理测试组合获得了0.865.5的AUC.

结论:

  • 将神经心理测试与血液生物标志物的结合可以提高早期AD的诊断性能.
  • 生物标志物在统计模型中的重要贡献引发了关于认知评估对查的唯一有用性的问题.
  • 需要进一步的研究,以优化生物标志物和认知测试的使用,以有效地早期诊断AD.